NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bioengineering



Delta LNGFR is a viable gene marker in engineered tissues



September 9th, 2004

Delta LNGFR is a viable gene marker in engineered tissues.

According to a study from the Netherlands, "the use of bone marrow derived stromal cells (BMSC's) for bone tissue engineering has gained much attention as an alternative for autologous bone grafting. Little is known however, about the survival and differentiation of the cells, especially in the clinical application. The aim of this study was to develop a method to trace goat BMSC's in vivo."

"We investigated retroviral genetic marking, which allows stable expression of the label with cell division. Goat BMSC's were subjected to an amphotropic envelope containing a MoMuLV-based vector...


Source: Blood Weekly (2004-09-09)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login